Statistical characteristics of moxifloxacin-induced QTc effect

Journal of Biopharmaceutical Statistics

Volumn 20, Issue 3, 2010, Pages 497-507

  Yan, Lihan K ^a   Zhang, Joanne ^a   Ng, Moh Jee ^a   Dang, Qianyu ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

Author keywords

Assay sensitivity; Moxifloxacin; Thorough QTc study

Indexed keywords

MOXIFLOXACIN; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CORRELATION ANALYSIS; DOSE RESPONSE; DRUG EFFECT; FEMALE; HUMAN; MALE; NORMAL HUMAN; PLASMA CONCENTRATION-TIME CURVE; PRIORITY JOURNAL; QT INTERVAL; QT PROLONGATION; SINGLE DRUG DOSE;

ADOLESCENT; ADULT; AGED; ANTI-INFECTIVE AGENTS; ARRHYTHMIAS, CARDIAC; AZA COMPOUNDS; CONTROLLED CLINICAL TRIALS AS TOPIC; CROSS-OVER STUDIES; DATA INTERPRETATION, STATISTICAL; ELECTROCARDIOGRAM PATTERN; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; MODELS, STATISTICAL; PLACEBO EFFECT; QUINOLINES; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; YOUNG ADULT;

EID: 77951689876     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543400903581945     Document Type: Article

References (6)

1. Bloomfield, D. M., Kost, J. T., Ghosh, K., Hreniuk, D., Hickey, L. A., Guitierrez, M. J., Gottesdiener, K., Wagner, J. A. (2008). The effect of moxifloxacin on QTc and implications for the design of thorough QT studies. Clin. Pharmacol. Ther. 84(4): 475-480.
2. International Conference on Harmonization. (2005). ICH (E14) Guidance. The Clinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential for Nonantiarrhythmic Drugs. International Conference on Harmonization, May, Geneva, Switzerland.
3. Lewis, M. J., Rassi, D., Short A. L. (2006). Analysis of the QT interval and its variability in healthy adults during rest and exercise. Physiol. Measure. 27:1211-1226. (Pubitemid 46063746)
4. Physician's Desk Reference. (2005). Monograph Avelox® (moxifloxacin HCl). Physicians Desk Reference Inc.
5. Stylianou, A., Roger, J., Stephens, K. (2008) A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies. J. Biopharm. Stat. 18:502-516. (Pubitemid 351891687)
6. Zhang, J. (2008) Testing for positive control activity in a thorough QTc study. J. Biopharm. Stat. 18:517-528. (Pubitemid 351891688)